Impulsive aggressive behavior: Open-label treatment with citalopram

Journal of Clinical Psychiatry

Volumn 64, Issue 1, 2003, Pages 81-85

  Reist, Christopher ^a,b   Nakamura, Katsura ^a   Sagart, Elahe ^a   Sokolski, Kenneth N ^a,b   Fujimoto, Ken A ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; SERENIC AGENT;

ADULT; AGGRESSION; ARTICLE; BARRATT IMPULSIVENESS SCALE; BUSS DURKEE HOSTILITY INVENTORY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; IMPULSIVENESS; MALE; OVERT AGGRESSION SCALE MODIFIED; PERSONALITY DISORDER; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 0037266268     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n0115     Document Type: Article

References (16)

1. Depue RA, Spoont MR. Conceptualizing a serotonin trait: a behavioral dimension constraint. Ann N Y Acad Sci 1986;487:47-62
2. 18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 1999;20: 413-423
3. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 1997;54: 1081-1088
4. Kavoussi RJ, Liu J, Coccaro EF. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994;55: 137-141
5. Bradford JM, Gratzer TG. A treatment for impulse control disorders and paraphilia: a case report. Can J Psychiatry 1995;40:4-5
6. Tandon R. Emerging antipsychotic treatments of violence. Presented at the 150th annual meeting of the American Psychiatric Association; May 17-22, 1997; San Diego, Calif
7. Markovitz PJ, Calabrese JR, Schulz SC, et al. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry 1991;48:1064-1067
8. Hollander E, DeCaria CM, Finkell JN, et al. Randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol Psychiatry 2000;47:813-817
9. Zimmerman M, Breen RB, Postemak MA. An open label study of citalopram in the treatment of pathological gambling. Presented at the 41st annual meeting of the New Clinical Drug Evaluation Unit; May 28-31, 2001; Phoenix, Ariz
10. Koran LM, Bullock KD, Hartston HJ, et al. Citalopram treatment of compulsive shopping: an open-label pilot study. Presented at the 41st annual meeting of the New Clinical Drug Evaluation Unit; May 28-31, 2001; Phoenix, Ariz
11. Coccaro EF, Harvey PD, Kupsaw-Lawrence E, et al. Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. J Neuropsychiatry Clin Neurosci 1991;3:44-51
12. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 1995;51:768-774
13. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol 1957;21:343-349
14. Montgomery SA, Asberg MC. A new depression rating scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389
15. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV (SCID I, Il). New York, NY: Biometric Research. New York State Psychiatric Institute; 1994
16. Salzman C, Wolfson AN, Schatzberg A, et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 1995;15:23-29